A- A A+

The Pandemic Stay-at-Home Order and Opioid-Involved Overdose Fatalities. 

Mason M, Arukumar P, Feinglass J. 

JAMA. 2021 Jun 22;325(24):2495-2496. doi: 10.1001/jama.2021.6700. PMID: 33890982.

https://jamanetwork.com/journals/jama/fullarticle/2779399

Patient adherence with infection control measures on a novel 'COVID-19 triage' psychiatric in-patient ward. 

Williams R, Tweed J, Rebolledo L, Khalid O, Agyeman J, Pinto da Costa M. 

BJPsych Open. 2021 Jul 14;7(4):e131. doi: 10.1192/bjo.2021.968. PMID: 34256887; PMCID: PMC8280465.

https://www.cambridge.org/core/journals/bjpsych-open/article/patient-adherence-with-infection-control-measures-on-a-novel-covid19-triage-psychiatric-inpatient-ward/79C7B6525C2A13A160854E6D39DBC0E9

Changes in drinking days among United States adults during the COVID-19 pandemic. 

Nordeck, C. D., Riehm, K. E., Smail, E. J., Holingue, C., Kane, J. C., Johnson, R. M., Veldhuis, C. B., Kalb, L. G., Stuart, E. A., Kreuter, F., and Thrul, J. (2021)

Addiction, doi.org/10.1111/add.15622.

https://onlinelibrary.wiley.com/doi/full/10.1111/add.15622

Changes in Admissions to Specialty Addiction Treatment Facilities in California During the COVID-19 Pandemic. 

Mark TL, Gibbons B, Barnosky A, Padwa H, Joshi V. 

JAMA Netw Open. 2021 Jul 1;4(7):e2117029. doi: 10.1001/jamanetworkopen.2021.17029. PMID: 34259852.

https://jamanetwork.com/journals/jamanetworkopen/fullarticle/2781940

Häusliche Gewalt vor und während der COVID-19-Pandemie

Ein Vergleich von zwei bevölkerungsrepräsentativen Befragungen

Domestic violence before and during the COVID-19 pandemic—a comparison of two representative population surveys

Dtsch Arztebl Int 2021; 118: 483-4; DOI: 10.3238/arztebl.m2021.0267

Kliem, Sören; Baier, Dirk; Kröger, Christoph

https://www.aerzteblatt.de/archiv/219991

Emergency Psychiatric Consultations During and After the COVID-19 Lockdown in Italy. A Multicentre Study. 

Balestrieri M, Rucci P, Amendola D, Bonizzoni M, Cerveri G, Colli C, Dragogna F, Ducci G, Elmo MG, Ghio L, Grasso F, Locatelli C, Mencacci C, Monaco L, Nicotra A, Piccinini G, Pischiutta L, Toscano M, Vaggi M, Villari V, Vitalucci A, Castelpietra G, Bondi E. 

Front Psychiatry. 2021 Jun 15;12:697058. doi: 10.3389/fpsyt.2021.697058. PMID: 34211413; PMCID: PMC8239213.

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8239213/

Studie belegt mangelnde Berücksichtigung von Geschlecht und Gender in klinischen Studien zu Covid-19

Obwohl sich das Coronavirus unterschiedlich auf Frauen und Männer auswirkt, stellt die große Mehrzahl der laufenden klinischen SARS-CoV-2- und Covid-19-Studien keinen Bezug zu Geschlecht und Gender her. Eine neue Metaanalyse von fast 4.500 klinischen Studien zeigt: Nur vier Prozent der ausgewerteten Studien sehen ausdrücklich vor, Geschlecht und Gender als Aspekte in ihre Analyse einzubeziehen. Für die Studie kooperierten Wissenschaftler*innen der Universität Bielefeld, des Radboud University Medical Center (Niederlande) sowie der Universitäten Aarhus und Kopenhagen (beide Dänemark). Das internationale Forschungsteam hat seine Analyse in Nature Communications veröffentlicht. (Universität Bielefeld, 07.07.2021)

https://idw-online.de/de/news772306

The association between opioids, environmental, demographic, and socioeconomic indicators and COVID-19 mortality rates in the United States: an ecological study at the county level. 

Qeadan F, Mensah NA, Tingey B, Bern R, Rees T, Madden EF, Porucznik CA, English K, Honda T. 

Arch Public Health. 2021 Jun 15;79(1):101. doi: 10.1186/s13690-021-00626-z. PMID: 34130741; PMCID: PMC8204068.

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8204068/

The Reasons for Higher Mortality Rate in Opium Addicted Patients with COVID-19: A Narrative Review. 

Dolati-Somarin A, Abd-Nikfarjam B. 

Iran J Public Health. 2021 Mar;50(3):470-479. doi: 10.18502/ijph.v50i3.5587. PMID: 34178794; PMCID: PMC8214617.

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8214617/

The Impact of the COVID-19 Pandemic on Self-Reported Management of Chronic Conditions. 

Imeri H, Holmes E, Desselle S, Rosenthal M, Barnard M. 

J Patient Exp. 2021 Apr 7;8:23743735211007693. doi: 10.1177/23743735211007693. PMID: 34179420; PMCID: PMC8205388.

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8205388/

Use of Alcohol and Addictive Drugs During the COVID-19 Outbreak in Norway: Associations With Mental Health and Pandemic-Related Problems. 

Bonsaksen T, Ekeberg Ø, Schou-Bredal I, Skogstad L, Heir T, Grimholt TK. 

Front Public Health. 2021 Jun 14;9:667729. doi: 10.3389/fpubh.2021.667729. PMID: 34195169; PMCID: PMC8236640.

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8236640/

USA. Unprecedented increase in overdose deaths during the COVID-19 pandemic – with substantial regional variation

After experiencing a slight decrease in 2018, drug overdose deaths increased again in 2019, setting an all-time high. Preliminary reports from states and cities indicate that overdose death rates are further increasing during the COVID-19 pandemic. (Recovery Research Institute, Juni 2021)

https://www.recoveryanswers.org/research-post/unprecedented-increase-overdose-deaths-covid-19-substantial-regional-variation/

Effects of the COVID-19 pandemic and lockdown on alcohol use disorders and complications. 

Murthy P, Narasimha VL. 

Curr Opin Psychiatry. 2021 Jul 1;34(4):376-385. doi: 10.1097/YCO.0000000000000720. PMID: 34016817; PMCID: PMC8183243.

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8183243/

Factors associated with alcohol and tobacco consumption as a coping strategy to deal with the coronavirus disease (COVID-19) pandemic and lockdown in Spain. 

Martínez-Cao C, de la Fuente-Tomás L, Menéndez-Miranda I, Velasco Á, Zurrón-Madera P, García-Álvarez L, Sáiz PA, Garcia-Portilla MP, Bobes J. 

Addict Behav. 2021 Oct;121:107003. doi: 10.1016/j.addbeh.2021.107003. Epub 2021 Jun 3. PMID: 34111653; PMCID: PMC8172276.

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8172276/

Differences in coronavirus disease 2019 screening, diagnosis, and hospitalization rates among U.S. pregnant women with and without a substance use disorder. 

Gao YA, Jarlenski MP, Chen Q, Krans EE. 

Am J Obstet Gynecol. 2021 Jun 8:S0002-9378(21)00635-9. doi: 10.1016/j.ajog.2021.06.004. Epub ahead of print. PMID: 34116037; PMCID: PMC8184873.

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8184873/

Changing Patterns of Substance Use During the Coronavirus Pandemic: Self-Reported Use of Tobacco, Alcohol, Cannabis, and Other Drugs. 

Benschop A, van Bakkum F, Noijen J. 

Front Psychiatry. 2021 May 26;12:633551. doi: 10.3389/fpsyt.2021.633551. PMID: 34122170; PMCID: PMC8187560.

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8187560/

Vascular comorbidities worsen prognosis of patients with heart failure hospitalised with COVID-19. 

Mok J, Malpartida JC, O'Dell K, Davis J, Gao C, Manyam H. 

Open Heart. 2021 Jun;8(1):e001668. doi: 10.1136/openhrt-2021-001668. PMID: 34127532; PMCID: PMC8206174.

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8206174/

USA. Drug Overdose Deaths Up 30% in Pandemic Year, Government Data Show

Substance use disorder also increases risk of contracting COVID, says NIDA director. (MedPage Today, USA, 01.06.2021)

https://www.medpagetoday.com/psychiatry/addictions/92876

Alcohol consumption during the COVID-19 pandemic in Europe: a large-scale cross-sectional study in 21 countries. 

Kilian, C., Rehm, J., Allebeck, P., Braddick, F., Gual, A., Barták, M., Bloomfield, K., Gil, A., Neufeld, M., O'Donnell, A., Petruželka, B., Rogalewicz, V., Schulte, B., Manthey, J., and the European Study Group on Alcohol Use and COVID-19 (2021) 

Addiction, doi.org/10.1111/add.15530

https://onlinelibrary.wiley.com/doi/full/10.1111/add.15530

Bottom-up citizen engagement for health emergency and disaster risk management: directions since COVID-19

Chan, Emily Ying Yang et al.

The Lancet, Volume 0, Issue 0 

https://www.thelancet.com/journals/lancet/article/PIIS0140-6736(21)01233-2/fulltext

Alkoholkonsum in Deutschland und Europa während der SARS-CoV-2 Pandemie

Jakob Manthey, Carolin Kilian, Georg Schomerus, Ludwig Kraus, Jürgen Rehm, and Bernd Schulte

SUCHT 2020 66:5, 247-258

https://econtent.hogrefe.com/doi/full/10.1024/0939-5911/a000686

Research on substance use disorders during the COVID-19 pandemic. 

Volkow ND, Blanco C. 

J Subst Abuse Treat. 2021 Apr 8;129:108385. doi: 10.1016/j.jsat.2021.108385. Epub ahead of print. PMID: 34080553; PMCID: PMC8028597.

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8028597/

Addiction Medicine After COVID-19: The Imperative of a Trained Workforce. 

Wu JH, Rich JD, Adashi EY. 

Am J Prev Med. 2021 May;60(5):729-731. doi: 10.1016/j.amepre.2020.11.007. Epub 2021 Jan 9. PMID: 33581936; PMCID: PMC7794594.

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7794594/

COVID-19: Mehr Depressionen bei Jugendlichen, aber weniger Drogen

Reykjavik – Die soziale Isolation, in die Jugendliche durch die Maßnahmen gegen SARS-CoV-2 geraten sind, hat mentale Spuren hinterlassen. Eine Umfrage unter isländischen Teenagern in Lancet Psychiatry (2021; DOI: 10.1016/S2215-0366(21)00156-5) zeigt, dass depressive Symptome zugenommen haben – während der Substanzmissbrauch zurückgegangen ist. (aerzteblatt.de, 07.06.2021)

https://www.aerzteblatt.de/nachrichten/124439/COVID-19-Mehr-Depressionen-bei-Jugendlichen-aber-weniger-Drogen

Health literacy and changes in pattern of drug use among participants at the Stockholm Needle Exchange Program during the COVID-19 pandemic. 

Lindqvist K, Wallmofeldt C, Holmén E, Hammarberg A, Kåberg M. 

Harm Reduct J. 2021 May 10;18(1):52. doi: 10.1186/s12954-021-00499-z. PMID: 33971892; PMCID: PMC8107802.

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8107802/

How Did COVID-19 Affect Suicidality? Data from a Multicentric Study in Lombardy. 

Gesi C, Grasso F, Dragogna F, Vercesi M, Paletta S, Politi P, Mencacci C, Cerveri G 

J Clin Med. 2021 May 29;10(11):2410. doi: 10.3390/jcm10112410. PMID: 34072386.

https://www.mdpi.com/2077-0383/10/11/2410

Risk factors for prospective increase in psychological stress during COVID-19 lockdown in a representative sample of adolescents and their parents. 

Paschke K, Arnaud N, Austermann MI, Thomasius R. 

BJPsych Open. 2021 May 3;7(3):e94. doi: 10.1192/bjo.2021.49. PMID: 33938424; PMCID: PMC8111205.

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8111205/

Exploring the Social Impacts of the COVID-19 Pandemic on People Living with HIV (PLHIV): A Scoping Review. 

Winwood JJ, Fitzgerald L, Gardiner B, Hannan K, Howard C, Mutch A. 

AIDS Behav. 2021 May 21:1–16. doi: 10.1007/s10461-021-03300-1. Epub ahead of print. PMID: 34019203; PMCID: PMC8137806.

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8137806/

Disruptions of neurological services, its causes and mitigation strategies during COVID-19: a global review. 

García-Azorín D, Seeher KM, Newton CR, Okubadejo NU, Pilotto A, Saylor D, Winkler AS, Charfi Triki C, Leonardi M. 

J Neurol. 2021 May 22:1–14. doi: 10.1007/s00415-021-10588-5. Epub ahead of print. PMID: 34021772; PMCID: PMC8140556.

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8140556/

WHO supports people quitting tobacco to reduce their risk of severe COVID-19

The World Health Organization’s 'Commit to Quit’ tobacco campaign has made resources from its Quitting Toolkit freely available to more than a billion tobacco users, less than 5 months into the year-long campaign.

WHO launched the campaign to support those millions of tobacco users who are actively taking steps to save their lives, but still need help to succeed. (WHO, Genf, 28.05.2021)

https://www.who.int/news/item/28-05-2021-who-supports-people-quitting-tobacco-to-reduce-their-risk-of-severe-covid-19